NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research report released on Saturday. The brokerage issued a sell rating on the medical device company’s stock.

NeuroMetrix Stock Up 2.3 %

Shares of NURO stock opened at $4.40 on Friday. NeuroMetrix has a 12-month low of $2.70 and a 12-month high of $9.87. The company has a market capitalization of $8.74 million, a P/E ratio of -0.71 and a beta of 2.28. The firm has a 50-day moving average price of $4.04 and a 200 day moving average price of $3.73.

NeuroMetrix (NASDAQ:NURO) last announced its quarterly earnings results on Thursday, February 22nd. The medical device company reported ($1.43) earnings per share (EPS) for the quarter. NeuroMetrix had a negative net margin of 110.64% and a negative return on equity of 31.31%. The firm had revenue of $1.32 million for the quarter.

Hedge Funds Weigh In On NeuroMetrix

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC bought a new position in NeuroMetrix, Inc. (NASDAQ:NURO) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned about 2.80% of NeuroMetrix at the end of the most recent quarter. 19.40% of the stock is currently owned by institutional investors.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.